ProPharma Group / Linden

ProPharma Group / Linden

October 6, 2016 - Monroe Capital Supports Linden Capital Partners’ Acquisition of ProPharma Group

Monroe Capital LLC today announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group (“ProPharma”) by private equity sponsor, Linden Capital Partners.

Founded in 2001 and based in Overland Park, Kansas, ProPharma is a leading provider of outsourced medical information, pharmacovigilance, and regulatory compliance consulting services to customers in the pharmaceutical, biotechnology, and medical device industries. The company has grown to a global organization operating five contact centers across the United States, Europe and Australia. ProPharma serves a customer base which includes many of the world’s largest and well-known biopharmaceutical companies.

About Monroe Capital

Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, asset based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors. Monroe has been recognized by Global M&A Network as the 2015, 2014, and 2013 Small Middle Markets Lender of the Year; Private Debt Investor as the 2015 Lower Mid-Market Lender of the Year, the 2014 Senior Lender of the Year, and the 2013 Unitranche Lender of the Year; and the U.S. Small Business Administration as the 2015 Small Business Investment Company (SBIC) of the Year. To learn more about Monroe Capital LLC, visit